Skip to main content

Dr. Michael Guerrera, MD

Pediatric Hematology & Oncology (Pediatric Hematology & Oncology Physician)

At a glance

Years since graduation
31
In the NPI registry since
2006

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 1995Medical school: University of Connecticut School of Medicine
  • 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Pediatric Hematology & Oncology Physician primary
    VA license 0101273594 · DC license MD31602
  • Pediatrics Physician
    VA license 0101273594

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Pediatric Hematology & Oncology per capita by county →

Where they work

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Payments from drug and device companies

In 2025, 2 companies reported 16 payments worth $46,559 in total to this clinician.

By type
Compensation for services other than consulting (speaking, faculty)$28,255
Consulting Fee$14,718
Travel and Lodging$3,258
Food and Beverage$329

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Sep 27, 2025Sanofi US Services Inc.
Sep 27, 2025
Consulting Fee$14,718
Jun 5, 2025Genzyme Corporation
Jun 5, 2025
Compensation for services other than consulting (speaking, faculty)
ALTUVIIIO · Hematology
$9,141
Aug 15, 2025Genzyme Corporation
Aug 15, 2025
Compensation for services other than consulting (speaking, faculty)
ELOCTATE; ALTUVIIIO · Hematology
$8,726
Oct 8, 2025Genzyme Corporation
Oct 8, 2025
Compensation for services other than consulting (speaking, faculty)
ALTUVIIIO · Hematology
$8,726
Apr 9, 2025Genzyme Corporation
Apr 9, 2025
Compensation for services other than consulting (speaking, faculty)
ALTUVIIIO · Hematology
$1,662
Jun 5, 2025Genzyme Corporation
Jun 5, 2025
Travel and Lodging
ALTUVIIIO · Hematology · travel to Syracuse, NY · in-kind
$1,110
Jun 5, 2025Genzyme Corporation
Jun 5, 2025
Travel and Lodging
ALTUVIIIO · Hematology · travel to Syracuse, NY · in-kind
$967
Oct 8, 2025Genzyme Corporation
Oct 8, 2025
Travel and Lodging
ALTUVIIIO · Hematology · travel to Richmond, VA · in-kind
$949
Jun 5, 2025Genzyme Corporation
Jun 5, 2025
Travel and Lodging
ALTUVIIIO · Hematology · travel to Syracuse, NY · in-kind
$215
Jun 5, 2025Genzyme Corporation
Jun 5, 2025
Travel and Lodging
ALTUVIIIO · Hematology · travel to Syracuse, NY
$16.00

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in District of Columbia →

Industry-funded research

Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $1,738 in research payments for these studies, mostly to the institutions running them.

  • A phase 3, prospective, multicenter, uncontrolled, open-label clinical study to determine the efficacy, safety, and tolerability of rvwf with or without advate in the treatment and control of bleeding episodes, the ef…
    Takeda Pharmaceuticals U.S.A., Inc.

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Pediatric Hematology & Oncology clinicians in Washington

Sources

NPI registry (CMS NPPES, November 2026; record last updated March 31, 2022), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1548354723. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.